PRMT5 and neoplastic syndrome: 4.3. Indirect Suppression of GLI1 Activity by PRMT5–Menin Complex-Mediated Epigenetic Modification in Multiple Endocrine Neoplasia Type 1 (MEN1) Tumor Syndrome